Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study
Buse, John B, Prof, Nauck, Michael, Prof, Forst, Thomas, Prof, Sheu, Wayne H-H, Prof, Shenouda, Sylvia K, PhD, Heilmann, Cory R, PhD, Hoogwerf, Byron J, MD, Gao, Aijun, PhD, Boardman, Marilyn K, PharmD, Fineman, Mark, PhD, Porter, Lisa, MD, Schernthaner, Guntram, Prof
Published in The Lancet (British edition) (12.01.2013)
Published in The Lancet (British edition) (12.01.2013)
Get full text
Journal Article
Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial
Diamant, Michaela, Prof, Van Gaal, Luc, Prof, Guerci, Bruno, Prof, Stranks, Stephen, MD, Han, Jenny, MS, Malloy, Jaret, PhD, Boardman, Marilyn K, PharmD, Trautmann, Michael E, Dr
Published in The lancet. Diabetes & endocrinology (01.06.2014)
Published in The lancet. Diabetes & endocrinology (01.06.2014)
Get full text
Journal Article
Safety of Exenatide Once Weekly in Patients With Type 2 Diabetes Mellitus Treated With a Thiazolidinedione Alone or in Combination With Metformin for 2 Years
Norwood, Paul, MD, FACP, Liutkus, Joanne F., MSW, MD, FRCP, Haber, Harry, MPH, Pintilei, Ella, MD, Boardman, Marilyn K., PharmD, Trautmann, Michael E., MD
Published in Clinical therapeutics (01.10.2012)
Published in Clinical therapeutics (01.10.2012)
Get full text
Journal Article